MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Pareidolias and color discrimination deficits differently correlate with cognitive dysfunction in prodromal Lewy body disease

    S. Kim, JH. Choi, KA. Woo, JY. Joo, HJ. Chang, B. Jeon, JY. Lee (Seoul, Republic of Korea)

    Objective: To investigate color discrimination ability and complex visual illusions known as pareidolias, and their associating factors in patients with iRBD compared to PD and…
  • 2023 International Congress

    Transferrin as a possible CSF biomarker in neurodegenerative proteinopathies

    K. Mensikova, P. Kanovsky, K. Klicova, D. Konickova, S. Kurcova, M. Nevrly, P. Otruba, Z. Grambalova, M. Kaiserova, J. Zapletalova (Olomouc, Czech Republic)

    Objective: The aim of this study was to determine whether cerebrospinal fluid (CSF) levels of transferrin differ between patients with Parkinson´s disease (PD), multiple system…
  • 2023 International Congress

    The East London Parkinson Disease Project – preliminary results from a diverse population

    A. Zirra, KC. Dey, E. Camboe, T. Haque, A. Ben-Joseph, J. Kahan, D. Gallagher, C. Budu, B. Huxford, C. Simonet, A. Lees, CR. Marshall, AJ. Noyce (London, United Kingdom)

    Objective: The East London Parkinson Disease (ELPD) project is a platform study to understand the manifestations and determinants of PD in a diverse population. Background:…
  • 2023 International Congress

    Clinal comprehensive Next-gen gene panel for Parkinson’s Disease

    Z. Niu, E. Lauer, S. Roellinger, L. Hasadsri, O. Ross, R. Savica (Rochester, USA)

    Objective: Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people. There is growing evidence on both gene mutations associated with PD and…
  • 2023 International Congress

    Effects of a nurse-led Advance Care Planning and Care Coordination intervention in Parkinson’s Disease – patient and family caregiver perspectives from a multicentre European study

    C. Muente, BW. Dijkstra, CM. Groot, MJ. Meinders (Nijmegen, Netherlands)

    Objective: To investigate an Advance Care Planning (ACP) and care coordination intervention from the perspective of people with Parkinson's disease (PwPD) and their family caregivers…
  • 2023 International Congress

    Gender-specific differences of gait in parkinsonian syndromes

    V. Sidoroff, F. Jagusch, P. Bachmann, N. Roth, N. Hergenröder-Lenzner, I. Teckenburg, A. Ibrahim, S. Büchner, D. Benninger, K. Seppi, F. Krismer, B. Eskofier, J. Winkler, J. Klucken, K. Aminian, H. Gassner, G. Wenning, C. Raccagni (Innsbruck, Austria)

    Objective: The aim of this study was to further assess gender-specific gait and balance differences related to fall frequency in APD and IPD patients. Background:…
  • 2023 International Congress

    Kufor-Rakef syndrome, report of two unrelated cases from Chile studied with DAT-PET

    P. Saffie, E. Fernandez, S. Mariacca, P. Salles, P. Chana (Santiago, Chile)

    Objective: To describe two previously unreported, unrelated cases of atypical parkinsonism caused by mutations in ATP13A2gene. Background: ATP13A2 gene, previously known as PARK 9, has recently…
  • 2023 International Congress

    Prevalence of cardiovascular drugs and oral anticoagulants use among persons with and without Parkinson’s disease

    B. Babar (Kuopio, Finland)

    Objective: We investigated prevalence of Cardiovascular drugs and Oral anticoagulants (OAC) use among community-dwelling persons with and without Parkinson's disease (PD) in relation to PD…
  • 2023 International Congress

    Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

    E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

    Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
  • 2023 International Congress

    Establishing a Natural History of X-linked Dystonia Parkinsonism

    P. Acuna, ML. Supnet-Wells, N. Spencer, JK. de Guzman, M. Russo, A. Hunt, C. Stephen, C. Go, S. Carr, N. Ganza-Bautista, JB. Lagarde, S. Begalan, T. Muthaupt-Buell, G. Aldykiewicz, L. Paul, L. Ozelius, C. Bragg, B. Perry, J. Green, J. Miller, N. Sharma (Roxas City, Philippines)

    Objective: Our main objective is to establish a comprehensive, quantitative assessment of movement dysfunction and bulbar motor impairments that are sensitive and specific to disease…
  • « Previous Page
  • 1
  • …
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • An atypical and interesting feature of Parkinson´s disease
    • Nilotinib for treating MSA: A preclinical proof of concept study
    • Effect of marijuana on Essential Tremor: A case report
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley